Wayne chats with Dr. Cartier Esham, CEO of Esham Strategies and Executive Director of the Alliance for a Stronger FDA. Together, they discuss FDA's proposed fiscal year 2027 budget, examine how it compares with past agency budgets, break down allocations and funding for multiple areas, look at Congress' role in budget review and approval, and much more. Learn more about the Alliance for a Stronger FDA at www.strengthenfda.org. This episode and all bonus episodes do not include the usual Headlines and Resources Links segments. To subscribe or find out more information about our podcast, visit FDAWatch.net. Want to be a sponsor, marketing partner, or guest, or provide feedback on the podcast? Email us at info@fdawatch.net. Music by <a class=
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from FDA Watch
FDA's Regulatory Revisions: Business & Legal Impact on Industry, Part 4 – Consumer Products
What's Next for Cosmetics and Personal Care Products?
A Fresh Look at the State of Human Foods
Where Does FDA Go From Here?
Get summaries like this every morning.
Free AI-powered recaps of FDA Watch and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.